Antibody Specificity Profiling with ProtoArray®
![]() |
Alleviate the risks early by testing your therapeutic antibody for cross reactivity
|
Why profile your antibody cross reactivity
-
Antibody specificity is crucial for the development of therapeutics.Cross reactivity can lead to serious unintended consequences.
FDA Guidance
"The Testing of Monoclonal Antibody Products for Human Use highlights the risk potential when the same or related antigenic determinant as targeted by the therapeutic antibody is expressed on human cells or tissues other than the intended target tissue."
U. S. Department of Health and Human Services
Food and Drug Administration
Center for Biologics Evaluation and Research
February 28,1997
FDA suggests that ‘appropriate newer technologies should be employed as they become available and validated’.
Why use ProtoArray® protein arrays?
-
ProtoArray® arrays are an excellent method to use for testing antibody specificity. Using this method you can profile your antibody against 9,000 functional proteins and identify possible cross reactivity. Since the identity of every protein on the array is known, you can immediately identify any proteins that your antibody binds to. The protocol is very straightforward and requires very little sample.
Protocol
Click here to view the pre- recorded Advanced Platforms for Discovery and Validation of Protein Therapeutics webinar that includes section on antibody specificity profiling using ProtoArray®.



